Exhibit 99.1
JOINT FILING AGREEMENT
The undersigned hereby agree that this Initial Statement on Schedule 13G with respect to the shares of Common Stock of Iovance Biotherapeutics, Inc., dated as of December 30, 2022, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
Date: December 30, 2022
MHR Capital Partners Master Account LP | ||
By: | /s/ Janet Yeung | |
Name:Janet Yeung | ||
Title:Authorized Signatory |
MHR ADVISORS LLC | ||
By: | /s/ Janet Yeung | |
Name:Janet Yeung | ||
Title:Authorized Signatory |
MHRC LLC | ||
By: | /s/ Janet Yeung | |
Name:Janet Yeung | ||
Title:Authorized Signatory |
MHR FUND MANAGEMENT LLC | ||
By: | /s/ Janet Yeung | |
Name:Janet Yeung | ||
Title:Authorized Signatory |
MHR HOLDINGS LLC | ||
By: | /s/ Janet Yeung | |
Name:Janet Yeung | ||
Title:Authorized Signatory |
MARK H. RACHESKY, M.D. | ||
By: | /s/ Janet Yeung, Attorney in Fact |